Healthcare Realty Trust Inc financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Healthcare Realty Trust Inc files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	461	614	696	692	500	535	933	1,344	1,268	1,181
General and administrative	28.8	33.4	35.2	41.4	30.7	34.2	52.7	58.4	83.1	72.6
Operating income	102	124
Interest expense	59.8	85.5	102	96.6	56.2	53.1	147	259	242	209
Other non-operating income	0.29	0.03	0.43	0.84	-7.22	-15.1	64.5	-336	-697	-342
Income from continuing operations					70.1	64.5	38.5
Net income to minority interests	1.43	1.66	4.16	0.6	0	0	-0.2	-3.82	-9.42	-3.41
Net income	45.9	63.9	213	30.2	72.2	66.7	40.9	-278	-654	-246
EBITDA	279	369
EPS, basic	0.74	0.76	2.25	0.33	0.52	0.45	0.15	-0.74	-1.81	-0.71
EPS, diluted	0.72	0.74	2.21	0.30	0.52	0.45	0.15	-0.74	-1.81	-0.71
Shares, basic (weighted)	63.1	83.6	95.1	94.9	134	143	252	379	366	350
Shares, diluted (weighted)	64.7	85.5	97	96.7	134	143	254	379	366	350
Dividend per share	2.58	2.62	2.67	2.71	1.20	1.21	1.24	1.24	1.24	1.10

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	11.2	100	126	32.7	115	13.2	61	25.7	68.9	26.2
Lease right-of-use assets			0	240	235	128	337	276	261	205
Goodwill						3.49	223	251	0
Intangible assets	278	459	373	278	239	212
Total assets	3,748	6,450	6,188	6,639	6,791	4,259	13,850	12,637	10,651	9,211
Total liabilities	1,963	3,079	2,847	3,208	3,556	2,074	6,168	5,714	5,345	4,534
Total debt	1,769	2,781	2,541	2,750	3,027	1,801	5,352	4,995	4,663	3,911
Paid-in capital	2,755	4,509	4,526	4,854	4,917	3,973	9,588	9,603	9,118	9,137
Other comprehensive income	0	0.27	0.31	4.55	-17	-7.04
Shareholders' equity	1,687	3,279	3,256	3,358	1,948	2,185	7,571	6,823	5,235	4,617
Minority interests	93.1	84.7	78.9	72.6	60.7	0	109	96.3	66.2	56.5
Total equity	1,780	3,363	3,335	1,900	1,948	2,185	7,680	6,919	5,301	4,673
Total liabilities and equity	3,748	6,450	6,188	6,639	6,791	4,259	13,850	12,637	10,651	9,211
Shares outstanding		94.6	94.7	99.9	219	150	381	381	351	352

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	47.3	65.6	218	30.8	72.2	66.7	40.7	-282	-664	-249
Depreciation and amortization	177	245	280	290	190	203	453	731	675	564
Stock-based compensation	7.07	6.87	9.76	10.1	9.92	10.7	20.3	14.3	31.8	22.4
Change in payables	2.17	37.4	9.48	-0.13	4.56	-0.84	24.2	-18.8	5.2	-25.5
Cash from operations	204	308	337	340	470	233	273	500	502	457
Capital expenditures	-43	-64.8	-77.9	-91.5	-74.7	-97.2
Cash from investing	-608	-2,455	176	-667	-555	-562	1,634	349	901	711
Debt issued	348	900	0	907	794	0
Debt repaid		0	0	-700	-47.8	-24.6	-20	-19.1	-25.5	-266
Stock issued	419	1,747	72.8	323	142	331	22.9	0.13	0.1	0
Share buybacks	-2.64	-3.41	-70.3	-12.2	-1.44	-3.8	-3.19	-2.3	-8.88	-4.01
Dividends paid	-159	-207	-253	-256	-163	-175	-284	-472	-458	-387
Cash from financing	401	2,241	-499	231	99.7	328	-1,859	-884	-1,359	-1,211
Net change in cash	-3.92	93.5	15	-95.9	14.6	-2.13	47.8	-35.3	43.2	-42.7
Free cash flow	161	243	260	249	395	135
Interest paid	50.9	65	101	94.7	52.8	49.4	113	216	203	177
Income taxes paid	1.06	1.33	1.65	2.13	0.56	0.56	1.83	1.32	1.79	1.26

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $18.05 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Net margin	-7.6%	Net income / revenue.
Operating cash flow margin	38.5%	Cash from operations / revenue.
Return on equity (ROE)	-2.1%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-1.0%	Net income / average total assets.
Stock-based pay / revenue	1.8%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	45.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-6.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	8.2%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	18.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-8.9%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	18.8%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-0.6%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	-11.3%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	-3.9%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	-1.7%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-11.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-15.2%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	18.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-13.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-12.7%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	6.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-4.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	11.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	21.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Debt / equity	0.99x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	46.3%	Total debt / total assets.
Liabilities / assets	52.5%	Total liabilities / total assets.
Net debt	$4.15B	Total debt - cash - short-term investments. Negative means more cash than debt.
Tangible book value	$4.22B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.13x	Revenue / average total assets.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.25	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$3.34	Revenue / diluted weighted shares.
Operating cash flow per share	$1.29	Cash from operations / diluted weighted shares.
Book value per share	$12.30	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$12.30	Tangible book value / shares outstanding.
Cash per share	$0.06	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$6.19B	Share price x shares outstanding.
Enterprise value	$10.33B	Market cap + total debt - cash - short-term investments.
P/S	5.40x	Market cap / revenue.
P/B	1.47x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.47x	Market cap / tangible book value, when positive.
P/OCF	14.0x	Market cap / cash from operations, when positive.
EV/Sales	9.03x	Enterprise value / revenue.
Earnings yield	-1.4%	Net income / market cap (the inverse of P/E).
Dividend yield	5.4%	Dividends paid over the period / market cap.
Shareholder yield	5.5%	(Dividends paid + share buybacks) / market cap.

What was Healthcare Realty Trust Inc's revenue in fiscal 2025?

Healthcare Realty Trust Inc reported revenue of $1.18B for fiscal 2025, 6.9% lower than the year before.

Was Healthcare Realty Trust Inc profitable in fiscal 2025?

No. It reported a net loss of $246.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Healthcare Realty Trust Inc